SABCS 2021: Switch to Fulvestrant Upon Early Signs of Rising ESR1 Mutations Improves Outcomes in HR-Positive Breast Cancer
Findings confirm that mutations to the estrogen receptor are independent of the estrogen hormone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.